|| We are looking for a highly-motivated and driven PhD student with a strong background in biochemistry and cell biology. Led by Dr. Matthias Voss who has recently been recruited as a junior group leader to the Institute for Biochemistry from Karolinska Institutet in Stockholm, Sweden, the newly established research group is interested in basic cellular processes in the context of human immunodeficiencies and malignant disease.
The position is associated with the DFG-funded collaborative research centre (SFB877) “Proteolysis as a Regulatory Event in Pathophysiology”. As such, the successful applicant will be participating in the centre’s Integrated Research Training Group, a student-organized graduate program established to promote interaction between the centre’s PhD students and support their training.
The SFB877 is embedded in Kiel’s strong life science focus, thus providing an inspiring environment for young researchers.
The group leader’s previous research interests include the physiological function of intramembrane proteases such as SPPL3 (Voss et al. (2014), EMBO J & Kuhn*, Voss* et al. (2015), Mol Cell Proteomics) and more recently the role of the twin tumour suppressors SAMD9 and SAMD9L in haematological cancers and innate immunity (Tesi*, Davidsson*, Voss* et al (2017), Blood). Accordingly, the PhD project will be performed in both cell culture and animal models and will rely on a vast array of techniques including live-cell confocal imaging, flow cytometry and proteomics. The PhD candidate will be working together with team members in Kiel and with collaborators within the research centre, but also abroad, e.g. in Stockholm. She or he will benefit from close scientific interactions with and focussed support by the supervisor.
Eligible candidates hold a Master's degree or equivalent in a relevant field (i.e. chemistry, biology, biochemistry, or medicine) and have previously demonstrated their expertise in molecular and cell biology techniques in an academic research lab. Good knowledge of written and spoken English language as well as excellent interpersonal and communication skills are required. In addition to a strong and broad interest in and knowledge of cell biology, immunology and cancer, in-depth prior experience with animal models, flow cytometry, imaging, CRISPR genome editing and other state-of-the-art methodologies is a plus.
The Christian-Albrechts-University aims to maintain a gender-balanced environment. We therefore specifically encourage women to apply for this position.
Applications from severely handicapped persons with basically similar qualifications will be given priority. Applications from foreign nationals are explicitly encouraged. Applications by people with a migration background are particularly welcomed
The position is available starting October 1st 2018 and fixed to 3 years initially. Salary is payed according to the German “Entgeltgruppe 13 TV-L”. Contracted hours are currently at 25,155 hours/week (65%).
Application deadline is October 26th 2018. Please send your application (incl. letter of motivation, copies of degree certificates and Master thesis as well as contact details of references) preferentially via e-mail. Refrain from submitting application photos.